![](/images/Email.png)
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 3.40nMAssay Description:Purified recombinant human FGFR4 protein was purchased from Carna Biosciences, Inc. When setting conditions for the measurement of the inhibitory ef...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 3.40nMAssay Description:The inhibitory effect of the compounds on FGFR4 kinase activity was measured according to the method of Test Example 3. Purified recombinant human FG...More data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
In DepthDetails
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 5.20nMAssay Description:Inhibition of human FGFR4 (445 to 753 residues) expressed in Escherichia coli BL21 (DE3) by HTRF assayMore data for this Ligand-Target Pair
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
In DepthDetails
TargetFibroblast growth factor receptor 4(Homo sapiens (Human))
Taiho Pharmaceutical Co., Ltd.
US Patent
Taiho Pharmaceutical Co., Ltd.
US Patent
![](/img/powered_by_small.gif)